Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2017 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway

  • Authors:
    • Guorong Chen
    • Huaji Jiang
    • Xinggui Tian
    • Jiajun Tang
    • Xiaochun Bai
    • Zhongmin Zhang
    • Liang Wang
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedics, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510630, P.R. China
    Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 5901-5907
    |
    Published online on: August 29, 2017
       https://doi.org/10.3892/mmr.2017.7380
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Excessive mechanical loading is a major factor affecting heterotopic ossification (HO), which is a major pathological alteration in calcific tendinopathy. However, physical therapies with mechanical loading as the functional element have exhibited promising results in the treatment of calcific tendinopathy. The dual effects that mechanical loading may have on the pathogenesis and rehabilitation of calcified tendinopathy remain unclear. The present study was designed to investigate the effects of mechanical loading on HO in calcific tendinopathy. In the present study, a tendon cell in vitro stretch model and an Achilles tenotomy rat model were used to simulate different elongation mechanical loading scenarios in order to investigate the effects of mechanical loading on HO of the tendon. In addition, rapamycin, a selective mammalian target of rapamycin complex‑1 (mTORC1) signaling pathway inhibitor, was employed to determine whether mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway. The data indicate that mechanical loading modulated HO of the tendon through the mTORC1 signaling pathway, and that low elongation mechanical loading attenuated HO, while high elongation mechanical loading accelerated HO in vivo. This study may improve the understanding of the effect of physical therapies used to treat calcific tendinopathy, so as to guide clinical treatment more effectively. Furthermore, rapamycin may be a potential drug for the treatment of calcific tendinopathy.

Introduction

The major pathological basis of calcific tendinopathy, the later stage of tendinopathy, is heterotopic ossification (HO) in the tendon, which severely affects health and quality of life, and can be career-ending for professional athletes (1). Treatment options for calcific tendinopathy are limited and tendon healing usually requires long-term rehabilitation (2). Physical therapies using mechanical loading as their functional element, such eccentric exercise, have shown promising results in the treatment of calcific tendinopathy (3,4). However, excessive mechanical loading is also a major factor in the pathogenesis of calcific tendinopathy and is associated with pain onset (5). The dual effects that mechanical loading may have in the pathogenesis and rehabilitation of calcified tendinopathy have not yet been fully clarified.

Mammalian target of rapamycin complex-1 (mTORC1), an evolutionarily-conserved serine-threonine kinase, controls protein synthesis, ribosome biogenesis and nutrient transport (6,7). Several studies have demonstrated that mechanical loading is sufficient for the activation of the mTORC1 signaling pathway because it can induce phosphorylation of p70 S6 kinase (P70S6K), a downstream protein in the mTORC1 signaling pathway (8–10). Previous studies using the mTORC1 inhibitor rapamycin or mTORC1 gene ablation demonstrated that mTORC1 signaling exerts either stimulatory or inhibitory effects on osteogenic differentiation, which leads to HO (11–14). Thus, mechanical loading may regulate osteogenic differentiation of tendon cells through the mTORC1 signaling pathway, however the mechanism remains unclear.

In the present study, an Achilles tenotomy rat model and a tendon cells stretch model were used to investigate the role mechanical loading may have in regulating HO of the tendon through the mTORC1 signaling pathway in calcific tendinopathy.

Materials and methods

Animals and treatment

A total of 50 male Sprague-Dawley rats [10 rats aged 2–3 weeks (50±5 g) and 40 rats aged 8 weeks (250±10 g)] were purchased from the Experimental Animal Research Center of Southern Medical University (Guangzhou, China) and housed in a specific pathogen-free animal facility with standard food and water under constant temperature (20–22°C), controlled humidity (45–55%) and a standard 12-h light/dark cycle. All animal experimental protocols were approved by the Animal Care and Use Committee of Southern Medical University and performed according to the Southern Medical University Guide for the Care and Use of Laboratory Animals.

Cell culture and mechanical loading stimulation

The middle portions of tendons used for cell culture were obtained from 10 Sprague-Dawley rats (aged 2–3 weeks, 50±5 g). The rats were sacrificed and the middle portion of tendons was obtained by cutting the tendon sample 5 mm from the tendon-muscle junction to tendon-bone insertion. The tendons were minced into small pieces (1 mm3) and digested with 0.1% collagenase type I (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) in 1 ml phosphate-buffered saline at 37°C for 1 h. After centrifugation at 1,000 × g at 37°C for 5 min and removal of the supernatant, a single-cell suspension was obtained, which was cultured in complete medium [CM; Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA] at 37°C with 5% CO2. Passages 3 and 4 were used for experiments in this study. For osteogenic differentiation, 1×105 cells were seeded into BioFlex six-well plates (Flexcell International Corporation, Burlington, NC, USA) in duplicate and incubated at 37°C in an atmosphere of 5% CO2. After 24 h incubation, medium containing non-adherent cells was removed and replaced with osteogenic induction medium (OIM). OIM consisted of α-MEM (Gibco; Thermo Fisher Scientific, Inc.), 10% FBS (Gibco; Thermo Fisher Scientific, Inc.), 50 µM ascorbic acid (Sigma-Aldrich; Merck KGaA), 0.1 µM dexamethasone (Sigma-Aldrich; Merck KGaA) and 10 mM β-glycero-phosphate (Sigma-Aldrich; Merck KGaA).

Mechanical loading was applied using the Flexcell FX-5000 Tension System (FX5K; Flexcell International Corporation). When cultures reached 60–70% confluence, cells were serum-starved for 24 h to arrest cells at G0. The cells were then subjected to mechanical stimulation, which was applied for 8 h daily for a week with the OIM replaced every 3rd day, using a sinusoidal waveform at a frequency of 0.5 Hz and a strain of 4 or 12%, with or without 10 nM rapamycin (Sigma-Aldrich; Merck KGaA). Control cultures were cultured under the same conditions without mechanical stimulation (NS).

Total RNA isolation and RT-qPCR analyses

Total RNA was extracted from cells using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) followed by cDNA synthesis performed with a StarScript II First-strand cDNA Synthesis kit (GenStar BioSolutions Co., Ltd., Beijing, China). The primers are listed in Table I. The RT-qPCR reactions were performed using RealStar Green Power Mixture with ROX (GenStar BioSolutions Co., Ltd) and an ABI Step One Plus PCR Detection System (Applied Biosystems; Thermo Fisher Scientific, Inc.). The thermocycling parameters were as follows: Pre-denaturation at 95°C for 2 min, followed by 40 cycles of denaturation at 94°C for 20 sec, annealing at 65°C for 20 sec and extension at 72°C for 30 sec. All assays were performed in triplicate and samples were normalized to GAPDH using the delta delta Cq method (15).

Table I.

Primer sequences for reverse transcription-quantitative polymerase chain reaction.

Table I.

Primer sequences for reverse transcription-quantitative polymerase chain reaction.

GenePrimer sequence
RUNX2F 5′-CACAAACAACCACAGAACCAC-3′
R 5′-TTGCTGTCCTCCTGGAGAAA-3′
OSXF 5′-CAAGAGTCGGATTCTAGGATTG-3′
R 5′-GATCAAACTTGCTGCAGGCTGCT-3′
GAPDHF 5′-GAGAGGCTCTCTGTCGACTAC-3′
R 5′-TAGTGTAGGTTGGGCGCTCAA-3′

[i] RUNX, runt-related transcription factor 2; OSX, osterix.

Western blot analyses

Following the stretching procedure, cells were rinsed with cold PBS and lysed in cold RIPA buffer [1×PBS, 1% NP-40, 0.5% sodium dexoycholate, 0.1% SDS, protease inhibitor cocktail tablet (Roche Diagnostics, Basel, Switzerland) and 1 mM phenylmethylsulfonyl fluoride (Beyotime Institute of Biotechnology)]. Lysates were incubated on ice for 20 min with frequent vortexing and cleared twice by centrifugation (11,000 × g, 10 min, 4°C). Protein was subjected to SDS-PAGE and transferred onto polyvinylidene difluoride membranes (EMD Millipore, Billerica, MA, USA). Membranes were blocked for 60 min at room temperature in 5% non-fat milk/Tris-buffered saline/0.1% Tween-20 (TBST). Following washing with TBST, the membranes were incubated overnight at 4°C in primary antibodies, which were phospho-P70S6K (Thr389; diluted 1:1,000 in 5% BSA; #9234; Cell Signaling Technology Inc., Danvers, MA, USA), runt-related transcription factor 2 (RUNX2; 1:1,000; #8486; Cell Signaling Technology, Inc.), osterix (OSX; 1:1,000; ab22552; Abcam, Cambridge, UK) or GAPDH (1:1,000; #2118; Cell Signaling Technology, Inc.). Membranes were incubated with the horseradish peroxidase-conjugated secondary antibody (1:2,000; #7047; Cell Signaling Technology, Inc.) at room temperature for 1 h, and subsequently washed. Image detection was performed according to the manufacturer's instructions using SignalFire enhanced chemiluminescence reagent (#6883; Cell Signaling Technology, Inc.). Data are representative of at least three experiments with similar results performed in triplicate. Images were analyzed using Image Pro-Plus 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA).

Establishment of animal model and drug treatment

A total of 40 male Sprague-Dawley rats aged 8 weeks and weighing 250±10 g were randomly distributed into 8 groups of 5 animals per group: Sham; Sham + rapamycin (Rapa); Control (Ctrl); Ctrl + Rapa; low elongation (LE); LE + Rapa; high elongation (HE); HE + Rapa. Rats were anesthetized with 10% chloral hydrate [300 mg/kg, intraperitoneally (i.p.)]. The rats in groups Ctrl, Ctrl + Rapa, LE, LE + Rapa, HE and HE + Rapa underwent midpoint Achilles tenotomy on the right leg through a posterior approach under aseptic conditions; rats in the Sham and Sham + Rapa groups received an incision only as a sham operation. Incisions were routinely closed with an interrupted 4-0 silk suture. Subsequently, the operated hind limbs of rats in Ctrl and Ctrl + Rapa groups and the non-operated hind limbs of the rats in the HE and HE + Rapa groups were fixed in plaster casts from the toes up to ~2.5 cm above the knee. The operated hind limbs of the rats in the LE and LE + Rapa groups were fixed in a plaster cast from ~1 cm below the ankle up to ~2.5 cm above the knee, allowing the toes to touch the ground directly. The ankle and knee were fixed at functional positions. The outer surface of the cast was coated with black pepper powder for protection (16). Thus, the animal models were established with three tendon stretch levels: Totally fixed (groups Ctrl and Ctrl + Rapa), low elongation stretch (groups LE and LE + Rapa) and high elongation stretch (groups HE and HE + Rapa). The rats in groups Sham + Rapa, Ctrl + Rapa, LE + Rapa and HE + Rapa received rapamycin (20 mg/kg/day, i.p.) every day for 6 weeks after operation (Table II).

Table II.

Establishment of animal model and drug treatments.

Table II.

Establishment of animal model and drug treatments.

GroupAchilles tenotomyRight leg total fixationRight leg partial fixationLeft leg total fixationRapa injection
Sham−−−−−
Sham + Rapa−−−−+
Ctrl++−−−
Ctrl + Rapa++−−+
LE+−+−−
LE + Rapa+−+−+
HE+−−+−
HE + Rapa+−−++

[i] Rapa, rapamycin; Ctrl, control; LE, low elongation; HE, high elongation.

Histological analyses

Following the operation, the tendon samples were immediately fixed in 4% buffered paraformaldehyde at 4°C for 24 h. The samples were then decalcified, embedded in paraffin, cut into 5 µm sections and placed on poly-L-lysine-coated slides for further procedures. For hematoxylin and eosin staining, the sections were stained with hematoxylin and eosin carried out according to the protocol in the product manual. For immunohistochemical staining, antigen retrieval of the sections was performed using the microwave method (17). Sections were incubated in 3% H2O2 at room temperature for 30 min to quench endogenous peroxidase activity, the sections were subsequently incubated with 10% normal goat serum (Gibco; Thermo Fisher Scientific, Inc.) at room temperature for 30 min to block nonspecific binding. The sections were then incubated with antibody against RUNX2 (diluted 1:100 in 5% BSA; ab23981; Abcam) and OSX (diluted 1:100; ab22552; Abcam), followed by incubation with goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (diluted 1:100; #7074; Cell Signaling Technology, Inc.). The protein of interest was visualized using 3,3′-diaminobenzidine using a light microscope and the images were analyzed by applying Image Pro-Plus 6.0 software (Media Cybernetics, Inc.).

Micro-computed tomography (µCT) analyses

µCT analysis of the right Achilles tendons was performed using a high-resolution µCT (Skyscan 1172; Bruker Corporation, Ettlingen, Germany). Hind limb samples were collected and fixed overnight at 4°C in 4% paraformaldehyde, then scanned using the settings 60 kV, 150 µA with a mean 20 µm slice thickness. The reconstructed tendon images were selected for quantification of bone mass. Bone volume density [bone volume/total volume (BV/TV)%], trabecular number (Tb.N; l/mm) and trabecular thickness (Tb.Th; mm) were calculated.

Statistical analyses

Data were analyzed using one-way analysis of variance while homogeneity of variance tests were used to evaluate data homogeneity (SPSS 21.0 software; IBM SPSS, Armonk, NY, USA). If the variances were equal, least-significant difference tests were employed; otherwise, Dunnett's tests were used. Results are presented as the mean ± standard deviation unless otherwise indicated. P<0.05 was considered to indicate a statistically significant difference.

Results

Low elongation mechanical loading attenuates HO while high elongation mechanical loading accelerates HO in vivo

In order to evaluate the effects of mechanical loading on HO in the Achilles tenotomy rat model, µCT analysis was employed (Fig. 1A and B). Compared with the ctrl group, lower BT/VT, Tb.N and Tb.Th were observed in the LE group; whereas the HE group exhibited higher BT/VT, Tb.N and Tb.Th compared with the control group. Hematoxylin and eosin staining revealed the same phenomenon (Fig. 1C). Therefore, these data suggested that the HO in rats was attenuated by low elongation mechanical loading, but enhanced by high elongation mechanical loading.

Figure 1.

Effects of mechanical loading on HO of Achilles tendon in rats. The rats in Ctrl, LE and HE groups underwent midpoint Achilles tenotomy on the right hind limbs; operated hind limbs of rats in the Ctrl group and the non-operated hind limbs of the rats in the HE group were fixed in plaster casts from the toes up to ~2.5 cm above the knee. The operated hind limbs of the rats in the LE group were fixed in a plaster cast from ~1 cm below the ankle up to ~2.5 cm above the knee, allowing the toes to touch the ground directly. The ankle and knee were fixed at functional positions. At 6 weeks after operation, the heterotopic ossification of the operated tendons were detected by using (A) µCT analysis. Scale bar, 100 µm. (B) BV/TV (bone volume density), Tb.N and Tb.Th were measured for each group. (C) Hematoxylin and eosin staining was performed on tendon sections from each group. Data represent the mean ± standard error, n=5. *P<0.05 vs. ctrl group. Ctrl, control; LE, low elongation; HE, high elongation; µCT, micro-computed tomography; BV/TV, bone volume/total volume; Tb.N, trabecular number; Tb.Th, trabecular thickness.

Low elongation mechanical loading reduces osteogenic differentiation and high elongation mechanical loading enhances osteogenic differentiation in vitro

Tendon cells in OIM were subjected to 4% elongation mechanical loading and protein and mRNA expression of RUNX2 and OSX were measured using western blot and RT-qPCR analyses, respectively. Protein and mRNA expression of RUNX2 and OSX were significantly decreased in the 4% stretch group compared with the NS group (P<0.05; Fig. 2A and B) while the 12% stretch group exhibited the opposite result (P<0.05; Fig. 2A and B). These data suggested that osteogenic differentiation in tendon cells was reduced by low elongation mechanical loading and enhanced by high elongation mechanical loading.

Figure 2.

Effects of mechanical loading on osteogenic differentiation of tendon cells. Tendon cells were subjected to 4 or 12% elongation mechanical stimulation in vitro, which was applied for 8 h daily for 1 week with the osteogenic induction medium replaced every 3rd day. NS control cells were cultures under the same conditions without mechanical stimulation. The level of RUNX2 and OSX were evaluated (A) at the translational level using western blot or (B) at the transcriptional level using RT-qPCR. Data represent the mean ± standard error, n=5. *P<0.05 vs. NS group. NS, no stimulation; RUNX, runt-related transcription factor 2; OSX, osterix.

mTORC1 signaling pathway was modulated by different levels of elongation mechanical loading in tendon cells

To examine the effects of mechanical loading on the mTORC1 signaling pathway in rat tendon cells, a downstream protein in the mTORC1 signaling pathway, p-P70S6K, was investigated using western blot analyses. Mechanical loading at 4% elongation decreased the protein expression of p-P70S6K, while mechanical loading at 12% elongation significantly increased p-P70S6K levels in rat tendon cells compared with the NS group (P<0.05; Fig. 3). These data suggested that low elongation mechanical loading suppressed the mTORC1 signaling pathway, while high elongation had the opposite effect on tendon cells.

Figure 3.

mTORC1 signaling pathway was influenced by different degrees of elongation mechanical loading in tendon cells. Tendon cells were subjected to 4 or 12% elongation mechanical stimulation in vitro, which was applied for 8 h daily for 1 week with the osteogenic induction medium replaced every 3rd day. NS control cells were cultured under the same conditions without mechanical stimulation. (A) Level of p-P70S6K was detected by western blotting and (B) relative band density was calculated. Data represent the mean ± standard error, n=5. *P<0.05 vs. NS group. NS, no stimulation; p-P70S6K, phospho-p70 S6 kinase.

mTORC1 inhibition blocks the effect of mechanical loading on osteogenic differentiation of tendon cells

In the in vitro tendon cells stretch model, the presence of rapamycin decreased protein expression of RUNX2 and OSX in the NS + Rapa group compared with the NS group (P<0.05; Fig. 4). Rapamycin-treated cells at 4% elongation mechanical loading decreased protein expression of RUNX2 and OSX compared with the untreated 4% group (P<0.05; Fig. 4). Additionally, the presence of rapamycin decreased 12% elongation mechanical loading-induced protein expression of RUNX2 compared with the untreated 12% group (P<0.05; Fig. 4). These data suggested that the osteogenic differentiation of tendon cells was mTORC1-dependent and that mechanical loading regulated the osteogenic differentiation of rat tendon cells through the mTORC1 signaling pathway.

Figure 4.

Rapa blocks the effect of mechanical loading on osteogenic differentiation of tendon cells. Tendon cells were subjected to 4 or 12% elongation mechanical stimulation, which was applied for 8 h daily for 1 week with the osteogenic induction medium, with or without 10 nM Rapa, replaced every 3rd day. NS control cells were cultures under the same conditions without mechanical stimulation. Level of RUNX2 and OSX were detected by western blotting and relative band density was calculated. Data represent the mean ± standard error, n=5. *P<0.05 vs. NS group; #P<0.05 vs. 4% group; +P<0.05 vs. 12% group. NS, no stimulation; Rapa, rapamycin; RUNX, runt-related transcription factor 2; OSX, osterix.

mTORC1 inhibition attenuates HO in rats

In order to investigate the roles the mTORC1 signaling pathway plays in mechanical loading-induced HO of the tendon, the mTORC1 selective inhibitor rapamycin was employed. The presence of rapamycin decreased expression of RUNX2 and OSX in rats in the Ctrl + Rapa group compared with the Ctrl group (Fig. 5). Rapamycin treated rats in the LE + Rapa group had decreased expression of RUNX2 and OSX compared with the untreated LE group (Fig. 5). Additionally, rapamycin decreased the HE mechanical loading-induced expression of RUNX2 and OSX in the HE + Rapa group compared with the untreated HE group (Fig. 5). These data suggested that HO in tendon was mTORC1-dependent and that mechanical loading regulated HO in rat tendon through the mTORC1 signaling pathway.

Figure 5.

Rapa attenuates HO of Achilles tendon in rats. The rats in groups Ctrl, Ctrl + Rapa, LE, LE + Rapa, HE and HE + Rapa underwent midpoint Achilles tenotomy on the right leg; operated hind limbs of rats in groups Ctrl and Ctrl + Rapa and the non-operated hind limbs of the rats in groups HE and HE + Rapa were fixed in plaster casts from the toes up to ~2.5 cm above the knee. The operated hind limbs of the rats in groups LE and LE + Rapa were fixed in a plaster cast from ~1 cm below the ankle up to ~2.5 cm above the knee, allowing the toes to touch the ground directly. The ankle and knee were fixed at functional positions. The rats in groups Ctrl + Rapa, LE + Rapa and HE + Rapa received 20 mg/kg/day Rapa intraperitoneally every day for 6 weeks after operation. Images presenting the immunohistochemical staining of (A) RUNX2 and (B) OSX at 6 weeks after operation. Scale bar, 50 µm. (C) Optical density data from RUNX2 and OSX stained sections. Data represent the mean ± standard error, n=5. *P<0.05 vs. Ctrl group; #P<0.05 vs. LE group; +P<0.05 vs. HE group. Ctrl, control; Rapa, rapamycin; LE, low elongation; HE, high elongation; RUNX, runt-related transcription factor 2; OSX, osterix.

Discussion

It was recently demonstrated that excessive mechanical loading may be a major factor involved in HO (5), which is the main pathological alteration of calcific tendinopathy; however, few studies have investigated the underlying mechanism. Therefore, the present study was established to investigate the underlying molecular mechanism of mechanical loading on heterotopic ossification in tendons.

Tendon stem cells or mesenchymal stem cells (MSCs) can be induced to differentiate into the osteogenic lineage following mechanical loading treatment, as evidenced by increased protein and mRNA expression levels of RUNX2 and OSX (18–20). In contrast, a previous study demonstrated that MSCs subjected to mechanical loading applied using an FX-4000T system had significantly decreased RUNX2 protein and mRNA expression (21). These contradictory results may have resulted from the different cell types and different parameters of the stretch equipment used in each experiment. In order to investigate the effects of relatively low and high elongation mechanical loading on osteogenic differentiation in tendon cells, 4 and 12% elongation were chosen to represent low and high elongation of mechanical loading, respectively. Runx2 and OSX, the primary regulators of osteogenic differentiation (22), were measured. The results indicated that low elongation mechanical loading promoted osteogenic differentiation of rat tendon cells. By contrast, high elongation mechanical loading suppressed osteogenic differentiation of rat tendon cells.

The Achilles tenotomy rat model has been used to investigate HO prophylaxis and treatment based on its relative simplicity and predictability (23–25). In the present study, the Achilles tenotomy rat model was employed to investigate how mechanical loading modulates HO in the tendon. The model was established with certain modifications by using plaster casts to simulate different levels of mechanical loading. Micro CT analysis of the BT/VT, Tb.N and Tb.Th parameters of tendon tissues suggested that HO in rats was attenuated by low elongation mechanical loading, but enhanced by high elongation mechanical loading. Through immunohistochemical and histological staining, the present study also revealed that low elongation mechanical loading downregulated RUNX2 and OSX by weakening mineralization, whereas high elongation mechanical loading exhibited the opposite effect. These results may illustrate that low elongation mechanical loading prohibited HO, while high elongation mechanical loading accelerated HO in the animal model.

Eccentric exercise, with mechanical loading as its functional element, has exhibited promising results in the treatment of calcific tendinopathy (3,4); however in other studies, eccentric exercise demonstrated relatively poor therapeutic effects (26,27). The present findings may explain how eccentric exercise has a therapeutic role through mechanical loading. The healing of tendons is a physiological process involving the dynamic equilibrium of micro-damage and micro-repair. This physiological process of healing may be changed into a pathologic process when the balance is broken. Thus, low elongation mechanical loading is preferred and excessive training should be avoided when receiving physical therapy.

In the present study, rapamycin, a selective mTORC1 signaling pathway inhibitor, exhibited capacity to inhibit osteogenic differentiation in vitro and attenuate HO in vivo. These results suggested that the mTORC1 signaling pathway may have a crucial role in the occurrence and development of HO. Previous studies have shown that mTORC1 signaling has an important role in modulating protein metabolism and energy metabolism (5,7,28). Therefore, the mTORC1 signaling pathway may modulate HO through the regulation of protein metabolism and energy metabolism. Thus, rapamycin may be a potential drug treatment for calcific tendinopathy.

In conclusion, the present study provided novel insights into the effects of mechanical loading on heterotopic ossification. The results demonstrated that low elongation mechanical loading attenuated HO while high elongation mechanical loading accelerated HO. Furthermore, mTORC1 signaling may be involved (Fig. 6) as an underlying mechanism in this process.

Figure 6.

Proposed mTORC1 signaling schematic in mechanical loading. Low elongation mechanical loading attenuated HO, while high elongation mechanical loading accelerated HO. mTORC1 signaling may be involved as an underlying mechanism in this process. mTORC1, mammalian target of rapamycin complex-1; HO, heterotopic ossification.

Acknowledgements

This work was supported by National Natural Science Foundation of China (NSFC; grant no. 31370985) and Natural Science Foundation of Guangdong Province of China (grant no. 2015A030310416).

References

1 

Kannus P and Józsa L: Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am. 73:1507–1525. 1991. View Article : Google Scholar : PubMed/NCBI

2 

Greis AC, Derrington SM and McAuliffe M: Evaluation and nonsurgical management of rotator cuff calcific tendinopathy. Orthop Clin North Am. 46:293–302. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Saithna A, Gogna R, Baraza N, Modi C and Spencer S: Eccentric exercise protocols for patella tendinopathy: Should we really be withdrawing athletes from sport? A systematic review. Open Orthop J. 6:553–557. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Larsson ME, Käll I and Nilsson-Helander K: Treatment of patellar tendinopathy-a systematic review of randomized controlled trials. Knee Surg Sports Traumatol Arthrosc. 20:1632–1646. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Gaida JE, Cook JL, Bass SL, Austen S and Kiss ZS: Are unilateral and bilateral patellar tendinopathy distinguished by differences in anthropometry, body composition, or muscle strength in elite female basketball players? Br J Sports Med. 38:581–585. 2004. View Article : Google Scholar : PubMed/NCBI

6 

Laplante M and Sabatini DM: mTOR signaling in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P and Sabatini DM: mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 110:163–175. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Burry M, Hawkins D and Spangenburg EE: Lengthening contractions differentially affect p70s6k phosphorylation compared to isometric contractions in rat skeletal muscle. Eur J Appl Physiol. 100:409–415. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Haddad F and Adams GR: Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy. J Appl Physiol (1985). 100:1188–1203. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Hornberger TA, Stuppard R, Conley KE, Fedele MJ, Fiorotto ML, Chin ER and Esser KA: Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism. Biochem J. 380:795–804. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Tong Y, Feng W, Wu Y, Lv H, Jia Y and Jiang D: Mechano-growth factor accelerates the proliferation and osteogenic differentiation of rabbit mesenchymal stem cells through the PI3K/AKT pathway. BMC Biochem. 16:12015. View Article : Google Scholar : PubMed/NCBI

12 

Chen C, Akiyama K, Wang D, Xu X, Li B, Moshaverinia A, Brombacher F, Sun L and Shi S: mTOR inhibition rescues osteopenia in mice with systemic sclerosis. J Exp Med. 212:73–91. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Rolfing JH, Baatrup A, Stiehler M, Jensen J, Lysdahl H and Bunger C: The osteogenic effect of erythropoietin on human mesenchymal stromal cells is dose-dependent and involves non-hematopoietic receptors and multiple intracellular signaling pathways. Stem Cell Rev. 10:69–78. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Gharibi B, Farzadi S, Ghuman M and Hughes FJ: Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells. Stem Cells. 32:2256–2266. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Bring DK, Kreicbergs A, Renstrom PA and Ackermann PW: Physical activity modulates nerve plasticity and stimulates repair after Achilles tendon rupture. J Orthop Res. 25:164–172. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Gu L, Cong J, Zhang J, Tian YY and Zhai XY: A microwave antigen retrieval method using two heating steps for enhanced immunostaining on aldehyde-fixed paraffin-embedded tissue sections. Histochem Cell Biol. 145:675–680. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Liu X, Chen W, Zhou Y, Tang K and Zhang J: Mechanical tension promotes the osteogenic differentiation of rat tendon-derived stem cells through the Wnt5a/Wnt5b/JNK signaling pathway. Cell Physiol Biochem. 36:517–530. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Li R, Liang L, Dou Y, Huan Z, Mo H, Wang Y and Yu B: Mechanical strain regulates osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cells. Biomed Res Int. 2015:8732512015.PubMed/NCBI

20 

Shi Y, Fu Y, Tong W, Geng Y, Lui PP, Tang T, Zhang X and Dai K: Uniaxial mechanical tension promoted osteogenic differentiation of rat tendon-derived stem cells (rTDSCs) via the Wnt5a-RhoA pathway. J Cell Biochem. 113:3133–3142. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Shi Y, Li H, Zhang X, Fu Y, Huang Y, Lui PP, Tang T and Dai K: Continuous cyclic mechanical tension inhibited Runx2 expression in mesenchymal stem cells through RhoA-ERK1/2 pathway. J Cell Physiol. 226:2159–2169. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Lee HW, Suh JH, Kim HN, Kim AY, Park SY, Shin CS, Choi JY and Kim JB: Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK. J Bone Miner Res. 32:1227–1237. 2008. View Article : Google Scholar

23 

Zhang K, Wang L, Zhang S, Yu B, Liu F, Cui Z, Jin D and Bai X: Celecoxib inhibits the heterotopic ossification in the rat model with Achilles tenotomy. Eur J Orthop Surg Traumatol. 23:145–148. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Lin L, Shen Q, Xue T and Yu C: Heterotopic ossification induced by Achilles tenotomy via endochondral bone formation: Expression of bone and cartilage related genes. Bone. 46:425–431. 2010. View Article : Google Scholar : PubMed/NCBI

25 

McClure J: The effect of diphosphonates on heterotopic ossification in regenerating Achilles tendon of the mouse. J Pathol. 139:419–430. 1983. View Article : Google Scholar : PubMed/NCBI

26 

Rompe JD, Furia J and Maffulli N: Eccentric loading compared with shock wave treatment for chronic insertional achilles tendinopathy. A randomized, controlled trial. J Bone Joint Surg Am. 90:52–61. 2008. View Article : Google Scholar : PubMed/NCBI

27 

Fahlström M, Jonsson P, Lorentzon R and Alfredson H: Chronic Achilles tendon pain treated with eccentric calf-muscle training. Knee Surg Sports Traumatol Arthrosc. 11:327–333. 2003. View Article : Google Scholar : PubMed/NCBI

28 

Zeng Z, Jing D, Zhang X, Duan Y and Xue F: Cyclic mechanical stretch promotes energy metabolism in osteoblast-like cells through an mTOR signaling-associated mechanism. Int J Mol Med. 36:947–956. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen G, Jiang H, Tian X, Tang J, Bai X, Zhang Z and Wang L: Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway. Mol Med Rep 16: 5901-5907, 2017.
APA
Chen, G., Jiang, H., Tian, X., Tang, J., Bai, X., Zhang, Z., & Wang, L. (2017). Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway. Molecular Medicine Reports, 16, 5901-5907. https://doi.org/10.3892/mmr.2017.7380
MLA
Chen, G., Jiang, H., Tian, X., Tang, J., Bai, X., Zhang, Z., Wang, L."Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway". Molecular Medicine Reports 16.5 (2017): 5901-5907.
Chicago
Chen, G., Jiang, H., Tian, X., Tang, J., Bai, X., Zhang, Z., Wang, L."Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway". Molecular Medicine Reports 16, no. 5 (2017): 5901-5907. https://doi.org/10.3892/mmr.2017.7380
Copy and paste a formatted citation
x
Spandidos Publications style
Chen G, Jiang H, Tian X, Tang J, Bai X, Zhang Z and Wang L: Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway. Mol Med Rep 16: 5901-5907, 2017.
APA
Chen, G., Jiang, H., Tian, X., Tang, J., Bai, X., Zhang, Z., & Wang, L. (2017). Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway. Molecular Medicine Reports, 16, 5901-5907. https://doi.org/10.3892/mmr.2017.7380
MLA
Chen, G., Jiang, H., Tian, X., Tang, J., Bai, X., Zhang, Z., Wang, L."Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway". Molecular Medicine Reports 16.5 (2017): 5901-5907.
Chicago
Chen, G., Jiang, H., Tian, X., Tang, J., Bai, X., Zhang, Z., Wang, L."Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway". Molecular Medicine Reports 16, no. 5 (2017): 5901-5907. https://doi.org/10.3892/mmr.2017.7380
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team